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Abstract
Background: Spinocerebellar ataxia (SCA) is a genetically heterogeneous disease. To date, 36 dominantly inherited
loci have been reported, and 31 causative genes have been identified.
Results: In this study, we analyzed a Japanese family with autosomal dominant SCA using linkage analysis and
exome sequencing, and identified CACNA1G, which encodes the calcium channel CaV3.1, as a new causative gene.
The same mutation was also found in another family with SCA. Although most patients exhibited the pure form of
cerebellar ataxia, two patients showed prominent resting tremor in addition to ataxia. CaV3.1 is classified as a low-
threshold voltage-dependent calcium channel (T-type) and is expressed abundantly in the central nervous system,
including the cerebellum. The mutation p.Arg1715His, identified in this study, was found to be located at S4 of
repeat IV, the voltage sensor of the CaV3.1. Electrophysiological analyses revealed that the membrane potential
dependency of the mutant CaV3.1 transfected into HEK293T cells shifted toward a positive potential. We established
induced pluripotent stem cells (iPSCs) from fibroblasts of the patient, and to our knowledge, this is the first report
of successful differentiation from the patient-derived iPSCs into Purkinje cells. There was no significant difference in
the differentiation status between control- and patient-derived iPSCs.
Conclusions: To date, several channel genes have been reported as causative genes for SCA. Our findings provide
important insights into the pathogenesis of SCA as a channelopathy.
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Background
Spinocerebellar ataxia (SCA) is characterized by cerebellar
ataxia, dysarthria, oculomotor disorder, extrapyramidal
sign, motor neuron sign, epilepsy, cognitive impairment,
and many other symptoms [1]. To date, 36 loci have been
shown to be involved in autosomal dominant SCA, and
the causative genes and mutations have been identified for
31 types of SCAs [2]. The majority of SCAs account for
repeat expansion, including a coding CAG repeat (SCA1–
3, 6, 7, 17, and dentatorubral-pallidoluysian atrophy)
causing misfolding of the encoded protein due to the ex-
panded polyglutamine tracts; groups of noncoding CAG,
CTG, ATTCT, and GGCCTG repeats (SCA8, 10, 12, and
36); and large TGGAA repeat insertions (SCA31) that in-
duce RNA-mediated gain-of-function mechanisms. The
remaining known SCA types are caused by single nucleo-
tide variants or indels (SCA5, 11, 13–15, 18–21, 23, 26–
28, 34, 35, 38, 40, and 41) in genes that encode various
functional proteins [2].
CACNA1A (MIM 601011) was first reported as a
causative gene of SCA6 (MIM 183086) among the genes
encoding channels [3, 4]. In recent years, potassium
channel mutations have been described in SCA13 (MIM
605259) and SCA19/22 (MIM 607346) [5–7]. Episodic
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ataxia (EA) is one of the diseases associated with SCA,
and some types of EA are caused by mutations in cal-
cium channel. CACNA1A and CACNB4 mutations lead
to EA2 (MIM 108500) and EA5 (MIM 613855), respect-
ively [8, 9]. Thus the ion channel dysfunction plays a key
role in the pathogenesis of ataxia and related diseases.
We have been engaged in clinicogenetic research using
the samples from more than 2,000 patients with SCA.
From a thorough examination of the disease types and
the geographical distributions of the 2,121 patients,
causative genes for 26.6 % of the dominant-inherited
cases (205 out of 721) are still unknown [10]. Therefore,
in order to identify novel causative genes, we applied ex-




We enrolled two Japanese families with segregating
dominant traits for cerebellar ataxia. There are 10 affected
individuals in the family 1 and five in the family 2. Blood
samples were obtained from eight affected individuals and
three unaffected individuals in family 1, and five affected
individuals and two unaffected individuals in family 2
(Fig. 1a). All patients were diagnosed with SCA by neurol-
ogists. Prior to this study, we confirmed that all affected
individuals had no pathogenic mutations causing SCA1–
3, 6, 8, and dentatorubral-pallidoluysian atrophy. The
study was approved by the Human Subjects Committees
of Hiroshima University; all subjects provided written in-
formed consent.
Linkage analysis
The samples used for linkage analysis were 1-III-2, 1-III-
4, 1-III-6, 1-III-8, 1-III-11, 1-III-13, 1-IV-2, 1-IV-3, and
1-IV-4. Because it was possible that 1-IV-3 and 1-IV-4
did not reach the appropriate age at onset, the two sam-
ples were treated as unknown in the pedigree file of link-
age analysis. Genomic DNA (gDNA) was extracted from
the peripheral lymphocytes of the participants according
to standard protocols. We used a Genome-Wide Human
SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA) for
genotyping of single nucleotide polymorphisms (SNPs),
and linkage analysis was performed by Allegro software,
estimating the dominant inheritance [11].
Exome Sequencing
Exome sequencing was carried out using three samples
from 1-III-6, 1-III-11, and 1-III-13, as previously de-
scribed [12]. For family 2, exome sequencing was also
performed with the sample from 2-III-1. gDNA libraries
were prepared using a SeqCap EZ Human Exome Library
v2.0 (Roche, Basel, Switzerland). Sequencing was per-
formed with 100-bp paired-end reads on a HiSeq2000
sequencer (Illumina, San Diego, CA, USA). We used
BWA (http://bio-bwa.sourceforge.net/) [13] for alignment
and mapping, Samtools (http://samtools.sourceforge.net/)
[14] and Picard (http://broadinstitute.github.io/picard/)
for SAM/BAM handling, GATK (http://www.broadinsti-
tute.org/gatk/) [15] and Samtools for variant calls, and
Annovar (http://annovar.openbioinformatics.org/) [16]
for annotation. Functional predictions due to amino
acid changes were estimated using PolyPhen-2 (http://
genetics.bwh.harvard.edu/pph2/) [17], SIFT (http://sift.
bii.a-star.edu.sg/) [18], and Mutation Taster (http://
www.mutationtaster.org/index.html) [19]. Control ex-
ome sequences were obtained from Japanese patients
undergoing exome analysis for diseases other than
SCA. All reported genomic coordinates were in
GRCh37/hg19. The identified mutations were validated
with a standard polymerase chain reaction (PCR)-
based amplification followed by sequence analysis with
an Applied Biosystems 3130 DNA sequencer (Thermo
Fisher Scientific, Waltham, MA, USA).
Expression vector
Wild-type CACNA1G (short isoform; BC110995.1,
NM_198382.2) in the pCMV-SPORT6 plasmid (pCMV-
SPORT6-CACNA1G) was purchased from Dharmacon
(Lafayette, CO, USA). The mutation c.5075G > A cor-
responding to c.5144G > A in the longest isoform
(NM_018896.4) was introduced by site-directed mutagen-
esis using QuikChange Lightning (Agilent Technologies,
Santa Clara, CA, USA) and verified by bidirectional se-
quencing. The IRES-EGFP sequence was amplified by PCR
from the pIRES-EGFP plasmid and inserted at the termin-
ation codon of the cDNA sequence in pCMV-SPORT6-
CACNA1G (pCMV-SPORT6-CACNA1G-IG) using an
In-Fusion HD Cloning Kit (TaKaRa Bio, Shiga, Japan).
Cell culture, transfection, and immunofluorescence
The primary antibodies used in this study were anti-
CACNA1G [20], and anti-alpha 1 sodium potassium
ATPase (Abcam, Cambridge, UK).
HeLa and HEK293T cells were maintained in Dulbec-
co’s modified Eagle’s medium (DMEM; Nakarai Tesque,
Kyoto, Japan) supplemented with 10 % fetal bovine
serum and penicillin/streptomycin (PS) in a 37 °C incu-
bator with 5 % CO2. For immunofluorescence analysis,
cells were grown on chamber slides (SCS-008; Matsu-
nami, Osaka, Japan) coated with poly-L-lysine (Sigma-
Aldrich, St. Louis, MO, USA), and were transiently
transfected with pCMV-SPORT6-CACNA1G using Li-
pofectamine LTX (Thermo Fisher Scientific, Waltham,
MA, USA), according to the manufacturer’s instructions.
After 48–72 h, the cells were fixed in 4 % paraformalde-
hyde, washed with phosphate-buffered saline (PBS),
blocked, and permeabilized with 0.2 % Tween20. Cells
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were incubated overnight at 4 °C with anti-CACNA1G
and anti-alpha 1 sodium potassium ATPase antibodies
and then treated with secondary antibodies. Images were
obtained using confocal microscopy (LSM510; Carl
Zeiss, Jena, Germany). The nuclei were visualized using
DAPI.
Cells for whole-cell patch clamping were grown in
glass-bottom plates (μ-Dish 35 mm low; ibidi, Martins-
ried, Germany) for 24 h following transfection with
SPORT6-CACNA1G-IG using Lipofectamine LTX.
Electrophysiology
Whole-cell recordings were made from GFP-expressing
HEK293T cells using an upright microscope (BX51WI;
Olympus, Tokyo, Japan) equipped with an IR-CCD cam-
era system (IR-1000; DAGE-MTI, Michigan, IN, USA) at
room temperature. The intracellular solution was com-
posed of 110 mM CsCl, 20 mM TEA-Cl, 10 mM NaCl,
5 mM EGTA, 10 mM HEPES, 4 mM Mg-ATP, and
0.4 mM 2Na-GTP (pH 7.3, adjusted with CsOH). The
pipette access resistance was about 2–3 MΩ. The com-
position of the extracellular solution was 10 mM NaCl,
105 mM TEA-Cl, 10 mM 4-AP, 2.5 mM KCl, 2 mM
CaCl2, 1 mM MgSO4, 1.25 mM NaH2PO4, 26 mM
NaHCO3, and 20 mM glucose, bubbled with 95 % O2
and 5 % CO2. Ionic currents were recorded with an
EPC-10 (HEKA Elektronik, Lambrecht, Germany). The
signals were filtered at 3 kHz and digitized at 20 kHz.
On-line data acquisition and off-line data analysis were
performed using PATCHMASTER software (HEKA
Elektronik, Lambrecht, Germany). Relative conductance
















Derivation of patient-specific fibroblasts and generation
of induced pluripotent stem cells (iPSCs)
Patient 2-III-1 harbored the CACNA1G mutation. Thus,
a 3-mm punched skin biopsy was obtained from the
upper arm. The skin sample was mechanically cut into
small pieces and cultured in 100-mm cell culture dishes
in DMEM containing 20 % fetal bovine serum. Out-
growth of dermal fibroblasts appeared after 7–14 days,
and cultures were split at 1:3 after reaching 80 % conflu-
ence. Peripheral blood was obtained from a healthy
donor after providing written informed consent in ac-
cordance with the institutional review board guidelines.
Peripheral blood mononuclear cells (PBMCs) were purified
by density gradient centrifugation with a BD Vacutainer
CPT (BD Biosciences, Franklin Lakes, NJ, USA) according
to the manufacturer’s instructions.
Human complementary DNAs for reprogramming fac-
tors were transduced into dermal fibroblasts and PBMCs
with episomal vectors (pCXLE-hOCT3/4-shp53-F, pCXLE-
hSK, and pCXLE-hUL; Addgene, Cambridge, MA, USA)
[21, 22]. The generated iPSCs were maintained on a mito-
mycin C-inactivated SNL feeder cell layer in DMEM/F12
containing GlutaMaxI (Thermo Fisher Scientific, Waltham,
MA, USA) supplemented with 20 % KnockOut Serum Re-
placement (KSR; Thermo Fisher Scientific, Waltham, MA,
USA), 5 ng/ml recombinant human FGF basic (Wako,
Osaka, Japan), 0.1 mM β-mercaptoethanol (Sigma-Aldrich,
St. Louis, MO, USA) and PS under 5 % CO2.
Purkinje cell differentiation from iPSCs
The differentiation of Purkinje cells from iPSCs was
performed as described previously [23, 24].
Results
Clinical manifestations
The proband 1-III-13 has exhibited the pure form of
cerebellar ataxia, and her age of at disease onset was
45 years. The main symptoms were ataxic gait, dysarth-
ria, and gaze-evoked horizontal nystagmus. Cognitive
impairment, epilepsy, muscle atrophy, involuntary move-
ment, and parkinsonism were not observed. The parents
did not exhibit the same symptoms; however, symptoms
were observed in her uncles. Her sister (1-III-11) also
suffered from the same symptoms, with slightly in-
creased severity. Other affected members in the family 1
showed similar clinical features, and the age at onset
varied from 20 to 70 years. In all patients, progression of
the disease was relatively slow.
(See figure on previous page.)
Fig. 1 Identification of a mutation in CACNA1G causing SCA. a Pedigree charts of families 1 and 2. Arrows indicate the probands. Filled and open
symbols represent affected and unaffected individuals, respectively. Genotypes of the variant c.5144G > A are shown under the number of
samples. Asterisks indicate the patients used for exome sequencing. b, c Results of linkage analysis. Arrows indicate the positions of CACNA1G. d
Sanger sequencing to confirm the CACNA1G variant. The reference nucleotide G is overlapped with variant nucleotide A in the mutant sample. e
Structure of CaV3.1 encoded by CACNA1G. The star indicates the position of the identified mutation. The mutation was located in the segment 4
(S4) of the fourth repeat. f Conservation at the location of the mutation. The nucleotide and amino acid sequences are completely conserved
among vertebrates. g Haplotype analysis. From the result of SNP genotyping, the haplotypes of both families around the CACNA1G gene
coincided for 360 kb
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For family 2, the age at onset ranged from 18 to
57 years. The main symptoms and clinical course were
similar to those in family 1, except that two patients 2-
II-2 and 2-III-2 showed prominent resting tremors.
In neuroimaging, brain magnetic resonance imaging
(MRI) results of 2-III-1 demonstrated cerebellar atrophy,
typical of SCA. However, the cerebrum and brainstem
showed no abnormalities (Additional file 1: Figure S1).
Candidate region from linkage analysis
From the results of linkage analysis, two regions where
logarithm of odds (LOD) score was 2 or more were ob-
tained in chromosomes 17 and 21 (Fig. 1b). The max-
imum LOD scores for chromosomes 17 and 21 were
2.1067 and 2.1066, respectively. The candidate region on
chromosome 17 was relatively wide, approximately
60 cM (Fig. 1c). The region did not correspond with any
genetic loci of known SCAs.
Variant filtration
The results of exome sequencing are shown in Additional
file 2: Table S1. More than 90,000 variants in each sample
were called. We narrowed down the candidate variants
based on filtering criteria consisting of open databases
(dbSNP, 1000 Genomes, and EPS 6400), genomic position,
function, and zygosity. A total of 386 variants were com-
mon to 1-III-6, 1-III-11, and 1-III-13. Among them, we
excluded variants that were observed in other diseases
from our in-house variant database, and 11 heterozy-
gous variants remained (Additional file 3: Table S2).
Variants that were estimated to be pathogenic by two
or more of the three prediction algorithms were as fol-
lows: SLC15A1, ALOX15B, CACNA1G, and RNF213.
We performed segregation of the variants with the dis-
ease in the 11 available subjects from family 1. The var-
iants in ALOX15B and CACNA1G were observed only
in affected subjects, but not in unaffected subjects.
Based on the linkage analysis, the variant of CACNA1G
was present in the high LOD region; therefore, we con-
cluded that CACNA1G was the most likely candidate.
This variant was confirmed by Sanger sequencing
(Fig. 1d).
Heterozygous mutation in CACNA1G
Chr17:48694921G >A corresponded to CACNA1G:c.
5144G >A, p.Arg1715His (NM_018896.4, MIM 604065)
(Fig. 1d). The CACNA1G gene encodes the CaV3.1 T-type
voltage-dependent calcium channel (VDCC). The nucleo-
tide and amino acid sequences of the mutated region were
found to be completely conserved among vertebrates
(Fig. 1f ). The structure of the calcium channel α sub-
unit, including CaV3.1, consisted of four repeating do-
mains (repeats I–IV) comprised of five hydrophobic
segments (S1–3, S5, and S6) and one positively charged
segment (S4) each [25]. The identified mutation was lo-
cated in S4 of repeat IV (Fig. 1e).
Identical heterozygous mutation was found in the vari-
ants obtained by exome sequencing for the sample from
2-III-1 of family 2. No other variants that caused SCA
were found in this patient. Sequencing of CACNA1G
throughout family 2 revealed that affected members har-
bored the mutation and unaffected members did not.
From the results of SNP genotyping performed for link-
age analysis, we compared the haplotypes around the
CACNA1G gene in the two families. Families 1 and 2
shared the haplotypes in the range of 10 and 19 Mb, re-
spectively. Both families shared the haplotypes for a
length of 360 kb (Fig. 1g).
Localization of mutant CaV3.1
Immunocytochemical studies were performed in order
to examine the possible changes in the subcellular
localization caused by the mutation. We used the NaK-
ATPase as a plasma membrane marker. Both wild-type
and mutant CaV3.1 were distributed diffusely in the
cytoplasm and the plasma membrane (Additional file 4:
Figure S2). No significant differences were observed in
the localizations of wild-type and mutant CaV3.1.
Electrophysiological properties
We examined changes in the electrophysiological prop-
erties of mutant CaV3.1. Whole-cell recording was ob-
tained from GFP-positive HEK293T cells expressing
wild-type or mutant CaV3.1. To isolate Ca
2+ currents,
HEK293T cells were bathed with the extracellular solu-
tion containing potassium channel blockers.
T-type VDCC currents were elicited by depolarizing
voltage steps after a hyperpolarizing prepulse to -100 mV
(300 ms) in HEK293T cells carrying wild-type and mutant
constructs (Fig. 2a). The peak current amplitudes are plot-
ted against step voltages in Fig. 2b. In HEK293T cells ex-
pressing the mutant construct, amplitudes of T-type
VDCC currents were significantly smaller at step voltages
of -60 and -70 mV, but not at higher membrane potential
depolarizations (Fig. 2a). This result suggested that the
maximum conductance was normal, but that activation of
mutant CaV3.1 was shifted to depolarized membrane po-
tentials. To further examine this phenomenon, the, esti-
mated relative conductances were calculated from the
peak current-voltage relationships. The reversal potentials
used for correction were estimated by line fits of peak am-
plitudes from -10 to +30 mV. For each cell, the relative
conductance was plotted against depolarizing voltage
pulses and fitted by a Boltzmann equation (Fig. 2c). The
averaged half-conductance potential of -57.5 ± 9.1 mV in
wild-type (n = 9, mean ± SD) was more hyperpolarized
than that of -44.7 ± 6.0 mV in mutant (n = 12; p = 0.004,
Mann-Whitney U-test), suggesting that activation of
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mutant CaV3.1 was significantly shifted toward more posi-
tive membrane potentials. In contrast, the slope factor
was not significantly different (wild-type, 6.4 ± 2.2 mV;
mutant, 6.2 ± 2.9 mV; p = 0.303), suggesting parallel shift
of membrane potential dependent curve to positive poten-
tials. Steady-state inactivation was calculated by fitting the
relative amplitudes of the currents as a function of the hy-
perpolarizing prepulse with the Boltzmann equation
(Fig. 2d). Similar to activation, the half-steady-state inacti-
vation potentials were significantly shifted to more posi-
tive membrane potentials (wild-type, -79.1 ± 6.6 mV;
mutant, -72.5 ± 5.5 mV; p < 0.025), but the slope factor
was not significantly different (wild-type, 6.3 ± 1.4 mV;
mutant, 7.7 ± 1.5 mV; p = 0.07). As a consequence, the
window current shifted toward more positive membrane
potentials. The kinetics of the T-type VDCC current were
also affected. The inactivation decay time constant of the
T-type VDCC currents was significantly slower at small
voltage steps in HEK293T cells expressing the mutant
construct (Fig. 2e). While it was not statistically signifi-
cant, a similar trend was also observed for the 10–90 %
rise time (Fig. 2f). These lines of evidence suggested that
the mutation affected the voltage dependency of activation
and inactivation of the CaV3.1 T-type VDCCs.
Fig. 2 Changes in electrophysiological properties. a Representative traces of T-type VDCC currents recorded from HEK293T cells expressing
wild-type (upper) or mutant (lower) CaV3.1. Holding potential was -60 mV. Voltage steps were applied after a hyperpolarizing prepulse to -100 mV
(duration = 500 ms). b Peak current-voltage plots of VDCC currents of wild-type (blue, n = 9) and mutant (red, n = 12) CaV3.1. c Relative
conductance-voltage plots. Each data point was calculated from data in B. The black line is a fit using the Boltzmann equation (see Methods).
d Steady state inactivation-voltage plots. The voltage step to -30 mV was preceded by incremental hyperpolarizing pulses (duration = 300 ms).
Data were obtained from the same cells shown in B and C. The black line is a fit using the Boltzmann equation (see Methods). e The decay time
constants of inactivation of the Ca2+ current plotted against voltage steps. f The 10–90 % rise times of Ca2+ currents plotted against voltage
steps. Data are presented as the mean ± SEM. Statistical significance was assessed by Mann-Whitney U-test. **p < 0.01, *p < 0.05
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Purkinje cells derived from iPSCs
We previously reported that the cerebellar neuroepithe-
lium self-organizes in 3D human embryonic stem cell
culture. The self-organized cerebellar neuroepithelium
differentiates into mature Purkinje cells [24]. To exam-
ine the ability of the generated iPSCs to differentiate into
Purkinje cells, we applied the 3D system to iPSC culture.
The differentiated iPSC-derived cells expressed L7. The
L7+ cells developed elaborate dendritic branches and
spines that were positive for Purkinje cell-specific glutam-
ate receptor GRID2 (Fig. 3, total culture days 51–58).
From the result of morphological evaluation of differenti-
ated Purkinje cells, dendritic field areas were 14,367 ±
1,026 μm2 in control (n = 6, mean ± SD) and 12,287 ±
954.8 μm2 in patient-derived iPSC (n = 6, mean ± SD;
Additional file 5: Figure S3A), and diameters of cell soma
were 29.8 ± 0.55 μm in control (n = 7, mean ± SD) and
30.09 ± 2.22 μm in patient-derived (n = 7, mean ± SD;
Additional file 5: Figure S3B). There were no obvious dif-
ferences in the differentiation potentials between control-
and patient-derived neurons immunocytochemically and
morphologically.
Discussion
Our study revealed that a mutation in CACNA1G en-
coding the T-type calcium channel CaV3.1 causes SCA.
This finding is consistent with the fact that several mu-
tations in channel-encoding genes have been reported
to cause SCA. We identified the mutation from a large
Japanese family with autosomal dominant SCA using
exome sequencing and linkage analysis. Moreover, the
same mutation was found in another Japanese family
with SCA.
The mutation was located in the S4 segment, which is
assumed as a part of the voltage sensor. In particular,
the substituted arginine is one of the positively charged
residues found every three amino acids; these residues
play a central role in voltage sensing. Since simultaneous
activation of all four voltage sensors is required to open
the calcium channel, the arginine residue mutated in the
affected individuals is electrophysiologically important
[26]. Our electrophysiological analysis supported this
concept. While the subcellular distribution and membrane
translocation of the protein were normal, membrane po-
tential dependency of activation and inactivation curves of
Ca2+ currents were positively shifted in HEK293T cells ex-
pressing mutant CaV3.1. Very recently, identical mutation
in CACNA1G was reported in French families, which also
demonstrated positive shifts in the window current of the
T-type channel [27]. Alterations of T-type Ca2+ currents
were consistent with our results. The mild physiological
changes could explain the clinical features of SCA, includ-
ing the age at onset and slow progression of the disease.
CaV3.1 is expressed in the cerebellum, inferior olive
nucleus, and the thalamus [28]. Physiologically, the
channel is associated with high-frequency burst firing of
more than 10 Hz and oscillation [29, 30] and regulates
the extension of the axons and dendrites in the develop-
mental stage [31]. In animal models, CaV3.1 has been
implicated in epilepsy. CaV3.1 knockout mice are unable
to elicit thalamocortical low-threshold calcium potentials
(LTCPs) and burst firing in response to hyperpolariza-
tion and are resistant to drug-induced absence seizures
[32]. Conversely, overexpression of CaV3.1 in transgenic
mice induces thalamocortical spike-wave oscillations
characteristic of pure absence epilepsy [33]. LTCPs of
the thalamus are also important for stabilizing NREM
sleep [34]. In another study using CaV3.1 knockout mice,
CaV3.1 expressed in the inferior olive was shown to be
associated with tremor [30].
The clinical picture of our patients was similar to that
of SCA6, caused by mutation in another type of calcium
channel, CACNA1A. Most patients exhibited the pure
form of cerebellar ataxia. Notably, two patients had rest-
ing tremors. CaV3.1 is expressed at high levels in the
cerebellum and inferior olive nucleus. Because T-type
VDCCs have important roles in the rhythmogenesis of
inferior olivery neurons [35], the symptom may also be
the consequence of the CaV3.1 mutation. Pyramidal tract
signs, which are characteristic of the French families,
were not prominent in our cases [27]. The fact that the
same mutation in the CACNA1G gene was independ-
ently identified in the different ethnics, Japanese and
French further supported the concept of CACNA1G as
Fig. 3 iPSC-derived Purkinje cells. Immunostaining of iPSC-derived
Purkinje cells on co-culture days 26. GRID2 was expressed in the L7+
dendritic spines. The scale bars represent 500 μm (upper panels) and
100 μm (lower panels)
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the causative gene for autosomal dominant SCA. Further
studies are needed to clarify the clinical characteristics
of the CACNA1G-dependent SCA in more detail.
In order to examine the role of CACNA1G in neuro-
genesis, iPSCs derived from the patient were differenti-
ated into Purkinje cells. There were no significant
defects in the morphology of Purkinje cells or the ex-
pression of Purkinje cell markers, and therefore, the mu-
tation likely did not affect the differentiation of the cells
into Purkinje cells. In the future, we are planning on
conducting a functional evaluation of induced Purkinje
cells.
Conclusions
In conclusion, we identified a mutation in CACNA1G
encoding the T-type calcium channel from two families
with dominantly inherited SCA. The mutation is located
in the crucial residue of the S4 segment, which functions
as a voltage sensor. Our electrophysiological study cor-
roborated these changes in channel properties, and thus,
the mutation was likely to be the cause of SCA. We indi-
cated the novel evidence that ion channel dysfunction
leads to the pathogenesis of SCA.
Additional files
Additional file 1: Figure S1. Brain MRI of the patient 2-III-1. The left
panel shows the T1-weighted sagittal image, and the right panel shows
the T1-weighted axial image. Marked cerebellar vermian atrophy was
observed. (PPTX 1622 kb)
Additional file 2: Table S1. Summary of exome sequencing. (XLSX 42 kb)
Additional file 3: Table S2. Candidate variants. (XLSX 35 kb)
Additional file 4: Figure S2. Confocal images of HeLa cells expressing
wild-type or p.Arg1715His mutant CaV3.1. HeLa cells were transiently
transfected with wild-type or p.Arg1715His mutant human CaV3.1 and
immunostained with anti- CaV3.1 antibodies (green) and anti-NaK-ATPase
antibodies (red) as a membrane marker. Scale bar is 20 μm. (PPTX 286 kb)
Additional file 5: Figure S3. Morphological measurement of
differentiated Purkinje cells. Dendritic field area (A) and diameter of cell
soma (B) were measured in differentiated Purkinje cells. Data are
presented as the mean ± SD. Statistical significance was assessed by
unpaired t-test. (PPTX 274 kb)
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